Don't want to miss the best from Business Standard?
Sales decline 4.70% to Rs 256.40 crore
Net profit of Marksans Pharma rose 30.73% to Rs 25.65 crore in the quarter ended September 2019 as against Rs 19.62 crore during the previous quarter ended September 2018. Sales declined 4.70% to Rs 256.40 crore in the quarter ended September 2019 as against Rs 269.04 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales256.40269.04 -5 OPM %13.0913.80 -PBDT38.6433.26 16 PBT33.6627.72 21 NP25.6519.62 31Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
